Search Site
  • 0
    My Cart

    Click Here to Find How Many Items You Have Added:)

    image loader

    Adding item(s) to cart......

Home >> Signaling Pathways >> Angiogenesis

Angiogenesis

Products for  Angiogenesis

  1. Cat.No. Product Name Information
  2. GC38873 α2β1 Integrin Ligand Peptide TFA α2β1 Integrin Ligand Peptide TFA Chemical Structure
  3. GC62380 αvβ1 integrin-IN-1 αvβ1 integrin-IN-1 Chemical Structure
  4. GC62566 αvβ1 integrin-IN-1 TFA αvβ1 integrin-IN-1 TFA Chemical Structure
  5. GC45269 (±)10(11)-DiHDPA (±)10(11)-DiHDPA is produced from cytochrome P450 epoxygenase action on docosahexaenoic acid. (±)10(11)-DiHDPA Chemical Structure
  6. GC41212 (±)10(11)-EpDPA Cytochrome P450 metabolism of polyunsaturated fatty acids produces numerous bioactive epoxide regioisomers. (±)10(11)-EpDPA Chemical Structure
  7. GC40466 (±)11(12)-EET

    (±)11(12)-EET is a fully racemic version of the R/S enantiomeric forms biosynthesized from arachidonic acid by cytochrome P450 enzymes.

     (±)11(12)-EET Chemical Structure
  8. GC41648 (±)13(14)-DiHDPA (±)13(14)-DiHDPA is a metabolite of docosahexaenoic acid that is produced via oxidation by cytochrome P450 epoxygenases. (±)13(14)-DiHDPA Chemical Structure
  9. GC41191 (±)13(14)-EpDPA Cytochrome P450 metabolism of polyunsaturated fatty acids produces numerous bioactive epoxide regioisomers. (±)13(14)-EpDPA Chemical Structure
  10. GC41653 (±)16(17)-DiHDPA (±)16(17)-DiHDPA is produced from cytochrome P450 epoxygenase action on docosahexaenoic acid. (±)16(17)-DiHDPA Chemical Structure
  11. GC41655 (±)19(20)-EDP Ethanolamide (±)19(20)-EDP ethanolamide is an ω-3 endocannabinoid epoxide and cannabinoid (CB) receptor agonist (EC50s = 108 and 280 nM for CB1 and CB2, respectively). (±)19(20)-EDP Ethanolamide Chemical Structure
  12. GC41203 (±)7(8)-EpDPA Docosahexaenoic acid is the most abundant ω-3 fatty acid in neural tissues, especially in the brain and retina. (±)7(8)-EpDPA Chemical Structure
  13. GC34069 (±)-Zanubrutinib ((±)-BGB-3111) (±)-Zanubrutinib ((±)-BGB-3111) Chemical Structure
  14. GC63797 (S)-Sunvozertinib (S)-Sunvozertinib Chemical Structure
  15. GC16195 2,4-DPD cell permeable, competitive inhibitor of HIF-PH 2,4-DPD Chemical Structure
  16. GC17368 2-Furoyl-LIGRLO-amide Protease-activated receptor agonist 2-Furoyl-LIGRLO-amide Chemical Structure
  17. GC38731 2-Furoyl-LIGRLO-amide TFA 2-Furoyl-LIGRLO-amide TFA Chemical Structure
  18. GC15084 2-Methoxyestradiol (2-MeOE2) Apoptotic, antiproliferative and antiangiogenic agent 2-Methoxyestradiol (2-MeOE2) Chemical Structure
  19. GC14282 3-acetyl-11-keto-β-Boswellic Acid A 5-lipoxygenase inhibitor 3-acetyl-11-keto-β-Boswellic Acid Chemical Structure
  20. GC49562 4-methoxy Estrone An active metabolite of estrone 4-methoxy Estrone Chemical Structure
  21. GC15557 A 205804 E-selectin/ICAM-1 expression inhibitor A 205804 Chemical Structure
  22. GC15192 A 286982 A LFA-1/ICAM-1 interaction inhibitor A 286982 Chemical Structure
  23. GC14831 AC 264613 PAR2 agonist,potent and selective AC 264613 Chemical Structure
  24. GC15290 AC 55541 PAR2 agonist,potent and selective AC 55541 Chemical Structure
  25. GC60551 Acalabrutinib D4 Acalabrutinib D4 Chemical Structure
  26. GC15453 ACP-196 irreversible BTK inhibitor ACP-196 Chemical Structure
  27. GC32083 Acriflavine Acriflavine Chemical Structure
  28. GC12487 Adaptaquin HIF-prolyl hydroxylase-2 (PHD2) inhibitor Adaptaquin Chemical Structure
  29. GC33416 AFP464 AFP464 Chemical Structure
  30. GC31679 ARQ 531 ARQ 531 Chemical Structure
  31. GC63896 AS-1763 AS-1763 Chemical Structure
  32. GC34133 ATN-161 ATN-161 Chemical Structure
  33. GC33837 ATN-161 trifluoroacetate salt (ATN-161 TFA salt) ATN-161 trifluoroacetate salt (ATN-161 TFA salt) Chemical Structure
  34. GC63658 Atopaxar Atopaxar Chemical Structure
  35. GC13562 AVL-292 Btk inhibitor AVL-292 Chemical Structure
  36. GC42887 Axitinib Sulfoxide Axitinib sulfoxide is a major inactive metabolite of the tyrosine kinase inhibitor axitinib. Axitinib Sulfoxide Chemical Structure
  37. GC15817 AY-NH2 Selective PAR4 agonist AY-NH2 Chemical Structure
  38. GC18152 AZ-3451

    A potent, and selective PAR2 antagonist with Kd of 13.5 nM.

     AZ-3451 Chemical Structure
  39. GC12698 BAY 87-2243 A HIF-1 inhibitor,potent and selective BAY 87-2243 Chemical Structure
  40. GC63846 BIIB091 BIIB091 Chemical Structure
  41. GC17560 BIO 1211 An α4β1 inhibitor,selective and high affinity BIO 1211 Chemical Structure
  42. GC14208 BIO 5192 α4β1 inhibitor BIO 5192 Chemical Structure
  43. GC60077 BIO5192 hydrate BIO5192 hydrate Chemical Structure
  44. GC50078 BIRT 377 Potent negative allosteric modulator of LFA-1 BIRT 377 Chemical Structure
  45. GC18717 BMS 986120 A selective PAR4 antagonist BMS 986120 Chemical Structure
  46. GC62872 BMS-587101 BMS-587101 Chemical Structure
  47. GC38893 BMS-688521 BMS-688521 Chemical Structure
  48. GC31760 BMS-935177 BMS-935177 Chemical Structure
  49. GC31713 BMS-986142 BMS-986142 Chemical Structure
  50. GC32844 BMS-986195 BMS-986195 Chemical Structure
  51. GC11063 BMX-IN-1 BMX (also termed ETK) kinase inhibitor BMX-IN-1 Chemical Structure
  52. GC50325 BOP Dual α9β1/α4β1 integrin inhibitor; preferentially mobilizes HSCs BOP Chemical Structure
  53. GC19333 BTK IN-1 BTK IN-1 is a potent BTK inhibitor, with an IC50 of <100 nM. BTK IN-1 Chemical Structure
  54. GC35561 Btk inhibitor 1 Btk inhibitor 1 Chemical Structure
  55. GC35562 Btk inhibitor 1 hydrochloride Btk inhibitor 1 hydrochloride Chemical Structure
  56. GC10924 Btk inhibitor 1 R enantiomer Btk kinase inhibitor Btk inhibitor 1 R enantiomer Chemical Structure
  57. GC35563 Btk inhibitor 1 R enantiomer hydrochloride Btk inhibitor 1 R enantiomer hydrochloride Chemical Structure
  58. GC62498 BTK inhibitor 17 BTK inhibitor 17 Chemical Structure
  59. GC64360 BTK inhibitor 18 BTK inhibitor 18 Chemical Structure
  60. GC32007 Btk inhibitor 2 Btk inhibitor 2 Chemical Structure
  61. GC50075 BTT 3033 Selective inhibitor of integrin α2β1 BTT 3033 Chemical Structure
  62. GC38128 c(phg-isoD-G-R-(NMe)k) TFA c(phg-isoD-G-R-(NMe)k) TFA Chemical Structure
  63. GC32042 Carotegrast Carotegrast Chemical Structure
  64. GC62143 Carotegrast methyl Carotegrast methyl Chemical Structure
  65. GC43198 CAY10717 CAY10717 is a multi-targeted kinase inhibitor that exhibits greater than 40% inhibition of 34 of 104 kinases in an enzymatic assay at a concentration of 100 nM. CAY10717 Chemical Structure
  66. GC33064 CG-806 (Luxeptinib) An inhibitor of FLT3/BTK and other kinases CG-806 (Luxeptinib) Chemical Structure
  67. GC13365 CGI-1746 Btk inhibitor CGI-1746 Chemical Structure
  68. GN10518 Chitosamine hydrochloride Extracted from natural chitin;Store the product in sealed, cool and dry condition Chitosamine hydrochloride Chemical Structure
  69. GN10308 Chlorogenic acid A phenolic product with antioxidant activity Chlorogenic acid Chemical Structure
  70. GC13559 Cilengitide Integrin inhibitor for αvβ3 and αvβ5 Cilengitide Chemical Structure
  71. GC61520 Cilengitide TFA Cilengitide TFA Chemical Structure
  72. GC45880 Cimetidine-d3 Cimetidine-d3 Chemical Structure
  73. GC13439 CNX-774 BTK inhibitor, orally active, irreversible and selective CNX-774 Chemical Structure
  74. GC17631 Combretastatin A4 tubulin polymerization inhibitor Combretastatin A4 Chemical Structure
  75. GN10535 Cucurbitacin B A natural compound with anti-cancer activity Cucurbitacin B Chemical Structure
  76. GC13050 CWHM-12 An inhibitor of αV integrins CWHM-12 Chemical Structure
  77. GC17610 Cyclo (-RGDfK) An inhibitor of αvβ3 integrin Cyclo (-RGDfK) Chemical Structure
  78. GA21306 Cyclo(-Arg-Gly-Asp-D-Tyr-Lys) c(RGDyK) has been radioiodinated or modified with chelators for use as radiopharmaceutical. Cyclo(-Arg-Gly-Asp-D-Tyr-Lys) Chemical Structure
  79. GC60117 Cyclo(-RGDfK) TFA Cyclo(-RGDfK) TFA Chemical Structure
  80. GC34141 Cyclo(Arg-Gly-Asp-D-Phe-Val) TFA Cyclo(Arg-Gly-Asp-D-Phe-Val) TFA Chemical Structure
  81. GC30111 Cyclo(RADfK) Cyclo(RADfK) Chemical Structure
  82. GC13923 Cyclo(RGDyK) An αVβ3 integrin inhibitor Cyclo(RGDyK) Chemical Structure
  83. GC49716 Cyclo(RGDyK) (trifluoroacetate salt) A cyclic peptide ligand of αVβ3 integrin Cyclo(RGDyK) (trifluoroacetate salt) Chemical Structure
  84. GC16647 Daprodustat(GSK1278863) HIF-prolyl hydroxylase inhibitor Daprodustat(GSK1278863) Chemical Structure
  85. GC31230 Dencichin (Dencichine) Dencichin (Dencichine) Chemical Structure
  86. GC38767 Deoxyshikonin A natural products with anti-tumor activity Deoxyshikonin Chemical Structure
  87. GC32449 Desidustat Desidustat Chemical Structure
  88. GC16973 DMOG A competitive HIF-PH inhibitor DMOG Chemical Structure
  89. GC16280 DMXAA (Vadimezan) A selective inhibitor of DT-diaphorase DMXAA (Vadimezan) Chemical Structure
  90. GC45767 Dovitinib-d8 Dovitinib-d8 Chemical Structure
  91. GC19128 E7820 E7820 is an angiogenesis inhibitor by suppressing integrin a2, a cell adhesion molecule expressed on endothelial cells. E7820 Chemical Structure
  92. GC18236 Echinomycin An inhibitor of HIF1mediated gene transcription Echinomycin Chemical Structure
  93. GC62182 Echistatin TFA Echistatin TFA Chemical Structure
  94. GC17236 Echistatin, α1 isoform Potent irreversible αVβ3 integrin antagonist Echistatin, α1 isoform Chemical Structure
  95. GC33043 EL-102 EL-102 Chemical Structure
  96. GC33634 Enarodustat (JTZ-951) Enarodustat (JTZ-951) Chemical Structure
  97. GC60807 ENMD-1068 hydrochloride ENMD-1068 hydrochloride Chemical Structure
  98. GC33170 ENMD-119 (ENMD 1198) ENMD-119 (ENMD 1198) Chemical Structure
  99. GC12447 Eptifibatide Glycoprotein (GP) IIb/IIIa inhibitor Eptifibatide Chemical Structure
  100. GC13139 FG-4592 (ASP1517) A HIF prolyl-hydroxylase inhibitor FG-4592 (ASP1517) Chemical Structure
  101. GC16638 FG2216 HIF-prolyl hydroxylase inhibitor FG2216 Chemical Structure

Items 1 to 100 of 251 total

per page
  1. 1
  2. 2
  3. 3

Set Descending Direction